BTK and food allergy: For example, one study is planning on looking at the oral janus kinase (JAK) inhibitor abrocitinib for food allergy (NCT05069831), while another is evaluating the efficacy of the Bruton's tyrosine kinase (BTK) inhibitor remibrutinib for the treatment of food allergy (NCT05432388).